1960. Mucosal rAd5 Immunization against SARS-CoV-2 Spike Elicits Cross-Reactive Nasal and Serum Neutralizing Antibodies and Protects Against Beta Variant Challenge in African Green...

por Flitter, Becca A, Tedjakusuma, Sarah N, Lester, Colin A, Neuhaus, Elena D, Johnson, Susan, Dora, Emery G, Peinovich, Nadine, Jegede, Clara B, Tucker, Sean N
Publicado 2022

Adenovirus type 5 SARS-CoV-2 vaccines delivered orally or intranasally reduced disease severity and transmission in a hamster model

por Langel, Stephanie N., Johnson, Susan, Martinez, Clarissa I., Tedjakusuma, Sarah N., Peinovich, Nadine, Dora, Emery G., Kuehl, Philip J., Irshad, Hammad, Barrett, Edward G., Werts, Adam, Tucker, Sean N
Publicado 2022